Kelly Kersten
0000-0001-7615-2594
Publication & Citation Trends
Publications
0 total
Neoadjuvant immune checkpoint blockade triggers persistent and systemic Treg activation which blunts therapeutic efficacy against metastatic spread of breast tumors OA
Cited by 17
Semantic Scholar
Tumor cell heterogeneity drives spatial organization of the intratumoral immune response in squamous cell skin carcinoma OA
Cited by 3
Semantic Scholar
An immunosuppressive tumor population drives immunotherapy resistance of heterogeneous tumors OA
Cited by 2
Semantic Scholar
Myeloid mechano-metabolic programming restricts anti-tumor immunity OA
Cited by 5
Semantic Scholar
MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling OA
Cited by 90
Semantic Scholar
IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer. OA
Cited by 172
Semantic Scholar
Uptake of tumor-derived microparticles induces metabolic reprogramming of macrophages in the early metastatic lung OA
Cited by 15
Semantic Scholar
MYC promotes immune-suppression in TNBC via inhibition of IFN signaling OA
Cited by 6
Semantic Scholar
Research Topics
Immune cells in cancer
(31)
Cancer Immunotherapy and Biomarkers
(27)
Immunotherapy and Immune Responses
(16)
Immune Cell Function and Interaction
(11)
Cancer Cells and Metastasis
(6)
Affiliations
University of California, San Francisco
Sanford Burnham Prebys Medical Discovery Institute
Discovery Institute
The Netherlands Cancer Institute
Parker Institute for Cancer Immunotherapy